Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Stanford University.
Recruitment status was  Recruiting
Study NCT00186537   Information provided by Stanford University

First Received on September 14, 2005.   Last Updated on December 1, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Insulin Resistance
Hypertriglyceridemia
Additional conditions recognized in this trial
Weight Loss
More general conditions related to this trial
Body Weight
Body Weight Changes
Dyslipidemias
Glucose Metabolism Disorders
Hyperinsulinism
Hyperlipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Signs and Symptoms
Interventions listed in this trial
Rosiglitazone
Fenofibrate
Weight Loss
More general drug interventions related to this trial
Antimetabolites
Hypoglycemic Agents
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Stanford University
Abbott


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services